Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

NCT02366884 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Anti-Bacterial Agents
DRUG: Anti-Fungal Agents
DRUG: Anti-Protozoal Agents

Sponsor

Dr. Frank Arguello Cancer Clinic

Collaborators

[object Object]